Maxcyte (MXCT) Current Leases (2020 - 2026)
Maxcyte's (MXCT) quarterly Current Leases came in at $1.4 million in Q1 2026, up 7.68% year-on-year from $1.3 million in Q1 2025, and down 5.63% on a QoQ basis from $1.5 million in Q4 2025.
Maxcyte (MXCT) Current Leases (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Current Leases data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Current Leases rose 7.68% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 7.68% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 68.52% from the prior year.
- Current Leases for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
- Over the last five years, Current Leases for MXCT reached as high as $1.5 million in Q4 2025 and fell as low as $152200.0 in Q3 2022.
- Historically, Current Leases has averaged $816270.6 across 5 years, with a median of $825000.0 in 2024.
- Across the five-year window, Current Leases slumped 73.41% in 2022 and jumped 392.99% in 2023, its largest moves.
- Year by year, Current Leases stood at $157000.0 in 2022, then jumped by 392.99% to $774000.0 in 2023, then advanced by 11.63% to $864000.0 in 2024, then soared by 68.52% to $1.5 million in 2025, then fell by 5.63% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 20.50 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | - |
| 10 | Maxcyte | 109.55 Mn | 109.55 Mn | 8.08 Mn | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 864,000.00 |
| Sep 30, 2024 | 907,000.00 |
| Jun 30, 2024 | 878,000.00 |
| Mar 31, 2024 | 825,000.00 |
| Dec 31, 2023 | 774,000.00 |
| Sep 30, 2023 | 698,700.00 |
| Jun 30, 2023 | 498,600.00 |
| Mar 31, 2023 | 475,200.00 |
| Dec 31, 2022 | 157,000.00 |
| Sep 30, 2022 | 152,200.00 |
| Jun 30, 2022 | 438,700.00 |
| Mar 31, 2022 | 480,200.00 |
| Dec 31, 2021 | 527,200.00 |
| Sep 30, 2021 | 572,300.00 |
| Jun 30, 2021 | 616,500.00 |